University: University of Southern California
Country: United States
He is currently a Professor and Director of the GMCB Graduate Program at USC Keck School of Medicine. He holds four patents on secreted Hsp90 as a drug candidate to treat chronic wounds and triple negative breast cancer and all the patents have entered their industrial development phases. His research program is currently supported by two NIH grants (RO1) and one VA research grant (with Dr. David Woodley, MD). He is the principal or co-author of many peer-reviews publications in biomedical journals, including Cell, Nature, Science, PNAS, Nature Medicine, Journal of Clinical Investigation (JCI), EMBO J, Molecular Cell Biology (MCB), Molecular Biology of Cell (MBC), Journal of Cell Biology (JCB), JCS and JBC. He is a frequent speaker at national and international levels. He has received many national and international awards. He has membership in various societies such as American Society of Microbiology (ASM), American Association for the Advancement of Science, etc.
His research interest focuses on Mechanisms of skin wound healing and skin cancer, signal transduction by growth factors/cytokines and extracellular matrices proteins, regulation of human skin cell and skin cancer cell motility, extracellular Hsp90.
Boffin Access Limited is committed to maintaining the integrity of the scholarly record to researchers. Therefore violation of professional ethical codes may lead to retract articles. Article(s) may be retracted if it is found to have serious flaws, reported misconduct research, constitute copyright infringement and plagiarism.
To help avoid the incorrect or misleading publications, please drop your message to
Enter your e-mail address to stay informed about published articles, issue releases and latest updates on journal activities.
We openly welcome feedback and constructive criticism. Your compliments, concerns and suggestions regarding our services will prove enormously helpful in making them even better.
Do you have an idea or suggestion that can influence the Open Access community? Send an email to: email@example.com
Copyright © 2020 Boffin Access Limited.